AI assistant
Sending…
PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2015
May 21, 2015
33488_dirs_2015-05-21_cbeca48a-040d-4f31-9e83-b94efa0f99ae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2014-04-09
Reporting Person: BRYCE RICHARD PAUL (SR VP, CLINICAL RESEARCH & DEV)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-09 | COMMON STOCK | P | 2 | $87.35 | Acquired | 2 | Direct |
| 2014-04-11 | COMMON STOCK | P | 28 | $82.49 | Acquired | 30 | Direct |
More from PUMA BIOTECHNOLOGY, INC.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8